Side effects of GLP-1 medications may be serious, including increased risk of thyroid tumors and cancer
doi: 10.14202/vetworld.2016.1287-1293 25 QureshiMAGarlichJDKiddMT
PMID: 37429996 Razmaray H, Nasiri E, Vakilipour P, Morsali S, Moradi A, Ebrahimian A, Rashidi S, Mosaddeghi-Heris R, Sadigh-Eteghad S, Naseri A (2024) The effects of melatonin supplementation on neurobehavioral outcomes and clinical severity in rodent models of multiple sclerosis
Asia Pacific to Register Fastest Growth at 14.1% CAGR Through Forecast Period The Asia Pacific GLP-1 receptor agonist market is projected to witness the fastest growth rate of CAGR 14.1% during the forecast period, driven by a rapidly rising prevalence of diabetes and obesity across major economies such as China, India, and Japan